Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on Sales

iHuman (IH) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for iHuman (IH) over the last 7 years, with Q3 2025 value amounting to 8.1%.

  • iHuman's EBITDA Margin fell 5500.0% to 8.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.56%, marking a year-over-year decrease of 331000.0%. This contributed to the annual value of 11.35% for FY2024, which is 70700.0% down from last year.
  • iHuman's EBITDA Margin amounted to 8.1% in Q3 2025, which was down 5500.0% from 9.74% recorded in Q2 2025.
  • In the past 5 years, iHuman's EBITDA Margin ranged from a high of 133.6% in Q4 2023 and a low of 16.94% during Q3 2021
  • Its 5-year average for EBITDA Margin is 14.22%, with a median of 8.75% in 2024.
  • As far as peak fluctuations go, iHuman's EBITDA Margin soared by 1185900bps in 2023, and later tumbled by -1271900bps in 2024.
  • Quarter analysis of 5 years shows iHuman's EBITDA Margin stood at 4.45% in 2021, then surged by 438bps to 15.01% in 2022, then soared by 790bps to 133.6% in 2023, then crashed by -95bps to 6.41% in 2024, then rose by 26bps to 8.1% in 2025.
  • Its EBITDA Margin was 8.1% in Q3 2025, compared to 9.74% in Q2 2025 and 10.26% in Q1 2025.